Role of Sociodemographic, Co-morbid and Intraoperative Factors in Length of Stay Following Primary Total Hip Arthroplasty

2015 ◽  
Vol 30 (12) ◽  
pp. 2092-2097 ◽  
Author(s):  
Ifeoma A. Inneh ◽  
Richard Iorio ◽  
James D. Slover ◽  
Joseph A. Bosco
2006 ◽  
Vol 21 (4) ◽  
pp. 89-92 ◽  
Author(s):  
Hugh U. Cameron ◽  
Louis Keppler ◽  
Tim McTighe

2018 ◽  
Vol 89 (6) ◽  
pp. 597-602 ◽  
Author(s):  
Jarry T Porsius ◽  
Nina M C Mathijssen ◽  
Lisette C M Klapwijk-Van Heijningen ◽  
Jeroen C Van Egmond ◽  
Marijke Melles ◽  
...  

2005 ◽  
Vol 23 (3) ◽  
pp. 542-548 ◽  
Author(s):  
J. V. Lunn ◽  
P. M. Gallagher ◽  
S. Hegarty ◽  
M. Kaliszer ◽  
J. Crowe ◽  
...  

2020 ◽  
Vol 133 (4) ◽  
pp. 801-811
Author(s):  
Eric S. Schwenk ◽  
Vincent P. Kasper ◽  
Jordan D. Smoker ◽  
Andrew M. Mendelson ◽  
Matthew S. Austin ◽  
...  

Background Early ambulation after total hip arthroplasty predicts early discharge. Spinal anesthesia is preferred by many practices but can delay ambulation, especially with bupivacaine. Mepivacaine, an intermediate-acting local anesthetic, could enable earlier ambulation than bupivacaine. This study was designed to test the hypothesis that patients who received mepivacaine would ambulate earlier than those who received hyperbaric or isobaric bupivacaine for primary total hip arthroplasty. Methods This randomized controlled trial included American Society of Anesthesiologists Physical Status I to III patients undergoing primary total hip arthroplasty. The patients were randomized 1:1:1 to 52.5 mg of mepivacaine, 11.25 mg of hyperbaric bupivacaine, or 12.5 mg of isobaric bupivacaine for spinal anesthesia. The primary outcome was ambulation between 3 and 3.5 h. Secondary outcomes included return of motor and sensory function, postoperative pain, opioid consumption, transient neurologic symptoms, urinary retention, intraoperative hypotension, intraoperative muscle tension, same-day discharge, length of stay, and 30-day readmissions. Results Of 154 patients, 50 received mepivacaine, 53 received hyperbaric bupivacaine, and 51 received isobaric bupivacaine. Patient characteristics were similar among groups. For ambulation at 3 to 3.5 h, 35 of 50 (70.0%) of patients met this endpoint in the mepivacaine group, followed by 20 of 53 (37.7%) in the hyperbaric bupivacaine group, and 9 of 51 (17.6%) in the isobaric bupivacaine group (P < 0.001). Return of motor function occurred earlier with mepivacaine. Pain and opioid consumption were higher for mepivacaine patients in the early postoperative period only. For ambulatory status, 23 of 50 (46.0%) of mepivacaine, 13 of 53 (24.5%) of hyperbaric bupivacaine, and 11 of 51 (21.5%) of isobaric bupivacaine patients had same-day discharge (P = 0.014). Length of stay was shortest in mepivacaine patients. There were no differences in transient neurologic symptoms, urinary retention, hypotension, muscle tension, or dizziness. Conclusions Mepivacaine patients ambulated earlier and were more likely to be discharged the same day than both hyperbaric bupivacaine and isobaric bupivacaine patients. Mepivacaine could be beneficial for outpatient total hip arthroplasty candidates if spinal is the preferred anesthesia type. Editor’s Perspective What We Already Know about This Topic What This Article Tells Us That Is New


2011 ◽  
Vol 12 (1) ◽  
Author(s):  
Rodrigo Jimenez-Garcıa ◽  
Manuel Villanueva-Martınez ◽  
Cesar Fernandez-de-las-Penas ◽  
Valentın Hernandez-Barrera ◽  
Antonio Rıos-Luna ◽  
...  

2020 ◽  
Vol 6 (4) ◽  
pp. 721-725
Author(s):  
Christian Gronbeck ◽  
Antonio Cusano ◽  
Justin M. Cardenas ◽  
Melvyn A. Harrington ◽  
Mohamad J. Halawi

Sign in / Sign up

Export Citation Format

Share Document